Oncology based Molecular Diagnostics Market Report

Oncology based Molecular Diagnostics Market Analysis By Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer) By Product (Instruments, Reagents), By Test Location, By Technology (PCR, Multiplex PCR, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Chips & Microarrays, Mass Spectrometry, Sequencing, Transcription Mediated Amplification) And Segment Forecasts To 2022

  • Published Date: Jan, 2016
  • Base Year for Estimate: 2015
  • Report ID: 978-1-68038-699-8
  • Format: Electronic (PDF)
  • Historical Data: 2013-2015
  • Number of Pages: 139

Table of Content

Chapter 1 Methodology and Scope
              1.1 Research Methodology
              1.2 Research Scope & Assumptions
              1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Oncology based Molecular diagnostics Industry Outlook
              3.1 Introduction
              3.2 Market Segmentation
              3.3 Market size and growth prospects
              3.4 Oncology based Molecular diagnostics: Market dynamics
                 3.4.1 Market driver analysis
                       3.4.1.1 Increasing prevalence of cancer
                       3.4.1.2 Rising demand for point of care treatment for oncology
                       3.4.1.3 Increasing demand for minimally invasive diagnostic procedures
                       3.4.1.4 Technology advancement
                       3.4.1.5 Growing healthcare expenditure triggering the need for effective diagnostic procedure for cancer
                 3.4.2 Market Restraint Analysis
                       3.4.2.1 High prices of molecular diagnostics tests
                       3.4.2.2 Presence of complicated regulatory framework
              3.5 Key Opportunities Prioritized
              3.6 Industry analysis Porter’s
              3.7 Oncology based Molecular diagnostics Market - Company Market Share Analysis, 2014
                 3.8.1 Recommendations for market participants
              3.9 Oncology based Molecular diagnostics: PESTEL Analysis
Chapter 4 Oncology based Molecular diagnostics Type Outlook
              4.1 Oncology based Molecular diagnostics market share by type, 2014 & 2022
              4.2 Breast Cancer
                       4.2.1.1 Breast cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
              4.3 Prostate Cancer
                       4.3.1.1 Prostate cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
              4.4 Colorectal Cancer
                       4.4.1.1 Colorectal cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
              4.5 Cervical Cancer
                       4.5.1.1 Cervical cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
              4.6 Liver Cancer
              4.6.1.1 Liver cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
              4.7 Lung Cancer
                       4.7.1.1 Lung cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
              4.8 Blood Cancer
                       4.8.1.1 Blood cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
              4.9 Kidney Cancer
                       4.9.1.1 Kidney cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
              4.10 Other Cancer
                       4.10.1.1 Other cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
Chapter 5 Oncology based Molecular diagnostics Product Outlook
              5.1 Oncology based Molecular diagnostics market share by product, 2014 & 2022
              5.2 Instruments
                 5.2.1 Instruments market, 2012 - 2022 (USD Million)
              5.3 Reagents
                 5.3.1 Reagents market, 2012 - 2022 (USD Million)
              5.4 Others
                 5.4.1 Others market, 2012 - 2022 (USD Million)
Chapter 6 Molecular diagnostics Test Location Outlook
              6.1 Molecular diagnostics market share by test location, 2014 & 2022
              6.2 Clinics and other establishments
                 6.2.1 Clinics and other establishments market, 2012 - 2022 (USD Million)
              6.3 Point of care
                 6.3.1 Point of care market, 2012 - 2022 (USD Million)
Chapter 7 Oncology based Molecular diagnostics Technology Outlook
              7.1 Oncology based Molecular diagnostics market share by technology, 2014 & 2022
              7.2 PCR
                 7.2.1 PCR market, 2012 - 2022 (USD Million)
                       7.2.1.1 Multiplex market, 2012 - 2022 (USD Million)
                       7.2.1.2 Multiplex PCR market, 2012 - 2022 (USD Million)
                       7.2.1.3 Other market, 2012 - 2022 (USD Million)
              7.3 TMA (Transcription Mediated Amplification)
                 7.3.1 Transcription Mediated Amplification (TMA) market, 2012 - 2022 (USD Million)
              7.4 In Situ Hybridization
                 7.4.1 In situ hybridization market, 2012 - 2022 (USD Million)
              7.5 Sequencing
                 7.5.1 Sequencing market, 2012 - 2022 (USD Million)
              7.6 INAAT (Isothermal Nucleic Acid Amplification Technology)
                 7.6.1 INAAT market, 2012 - 2022 (USD Million)
              7.7 Chips and microarrays
                 7.7.1 Chips and microarrays market, 2012 - 2022 (USD Million)
              7.8 Mass spectrometry
                 7.8.1 Mass spectrometry market, 2012 - 2022 (USD Million)
              7.9 Other technologies
                 7.9.1 Other market, 2012 - 2022 (USD Million)
Chapter 8 Oncology based Molecular diagnostics Regional Outlook
              8.1 Oncology based Molecular diagnostics Revenue Share by Region, 2014& 2022
              8.2 North America
                 8.2.1 North America Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.2.2 U.S.
                 8.2.3 U.S. Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.2.4 Canada
                 8.2.5 Canada Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
              8.3 Europe
                 8.3.1 Europe Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.3.2 UK
                 8.3.3 UK Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.3.4 Germany
                 8.3.5 Germany Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.3.6 France
                 8.3.7 France Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.3.8 Spain
                 8.3.9 Spain Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.3.10 Italy
                 8.3.11 Italy Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
              8.4 Asia Pacific
                 8.4.1 Asia Pacific Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.4.2 Japan
                 8.4.3 Japan Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.4.4 China
                 8.4.5 China Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.4.6 India
                 8.4.7 India Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.4.8 Australia
                 8.4.9 Australia Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.4.10 New Zealand
                 8.4.11 New Zealand Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
              8.5 Latin America
                 8.5.1 Latin America Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.5.2 Brazil
                 8.5.3 Brazil Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.5.4 Mexico
                 8.5.5 Mexico Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.5.6 Colombia
                 8.5.7 Colombia Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
              8.6 MEA
                 8.6.1 MEA Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.6.2 South Africa
                 8.6.3 South Africa Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
                 8.6.4 Saudi Arabia
                 8.6.5 Saudi Arabia Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
Chapter 9 Competitive Landscape
              9.1 Abbott Laboratories
                 9.1.1 Company Overview
                 9.1.2 Financial Performance
                 9.1.3 Product Benchmarking
                 9.1.4 Strategic Initiatives
              9.2 Bayer Healthcare
                 9.2.1 Company Overview
                 9.2.2 Financial Performance
                 9.2.3 Product Benchmarking
                 9.2.4 Strategic Initiatives
              9.3 Becton Dickinson
                 9.3.1 Company Overview
                 9.3.2 Financial Performance
                 9.3.3 Product Benchmarking
                 9.3.4 Strategic Initiatives
              9.4 Cepheid
                 9.4.1 Company Overview
                 9.4.2 Financial Performance
                 9.4.3 Product Benchmarking
                 9.4.4 Strategic Initiatives
              9.5 Dako
                 9.5.1 Company Overview
                 9.5.2 Financial Performance
                 9.5.3 Product Benchmarking
                 9.5.4 Strategic Initiatives
              9.6 Danaher Corporation
                 9.6.1 Company Overview
                       9.6.1.1 Beckman Coulter
                       9.6.1.2 Leica Biosystems
                 9.6.2 Financial Performance
                 9.6.3 Product Benchmarking
                 9.6.4 Strategic Initiatives of Danaher Corporation
                       9.6.4.1 Strategic Initiatives of Beckman Coulter Inc.
                       9.6.4.2 Strategic Initiatives of Leica Biosystems
              9.7 Gen Probe(Hologic)
                 9.7.1 Company Overview
                 9.7.2 Financial Performance
                 9.7.3 Product Benchmarking
              9.8 Qiagen N.V.
                 9.8.1 Company Overview
                 9.8.2 Financial Performance
                 9.8.3 Product Benchmarking
                 9.8.4 Strategic Initiatives
              9.9 Roche Diagnostics
                 9.9.1 Company Overview
                 9.9.2 Financial Performance
                 9.9.3 Product Benchmarking
                 9.9.4 Strategic Initiatives
              9.10 Siemens Healthcare
                 9.10.1 Company Overview
                 9.10.2 Financial Performance
                 9.10.3 Product Benchmarking
                 9.10.4 Strategic Initiatives
              9.11 Sysmex Corporation
                 9.11.1 Company Overview
                 9.11.2 Financial Performance
                 9.11.3 Product Benchmarking
                 9.11.4 Strategic Initiatives


List of Tables

TABLE 1 Oncology based Molecular diagnostics - Industry Snapshot & Key Buying Criteria, 2012 - 2022
TABLE 2 Oncology based Molecular diagnostics market, by type, 2012 - 2022 (USD Million)
TABLE 3 Oncology based Molecular diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 4 Molecular diagnostics market, by technology, 2012 - 2022 (USD Million)
TABLE 5 Molecular diagnostics market, by test location, 2012 - 2022 (USD Million)
TABLE 6 Molecular diagnostics market, by region, 2012 - 2022 (USD Million)
TABLE 7 Oncology based Molecular diagnostics - Key market driver analysis
TABLE 8 Global cancer incidences, 2012
TABLE 9 North America cancer incidences in 2012
TABLE 10 Europe cancer incidences, 2012
TABLE 11 Asia cancer incidences, 2012
TABLE 12 Africa cancer incidences, 2012
TABLE 13 Australia and New Zealand cancer incidences in 2012
TABLE 14 Oncology: Point of care treatment (POCT)
TABLE 15 Oncology: Molecular diagnostic techniques
TABLE 16 Healthcare expenditure levels, 2012
TABLE 17 Oncology based Molecular diagnostics - Key market restraint analysis
TABLE 18 Global breast cancer based molecular diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 19 Global breast cancer based molecular diagnostics market, by technology, 2012 - 2022 (USD Million)
TABLE 20 Global breast cancer based PCR market, by segments, 2012 to 2022 (USD million)
TABLE 21 Global breast cancer based molecular diagnostics market, by test location, 2012 - 2022 (USD Million)
TABLE 22 Global breast cancer based molecular diagnostics market, by region, 2012 - 2022 (USD Million)
TABLE 23 Global prostate cancer based molecular diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 24 Global prostate cancer based molecular diagnostics market, by technology, 2012 - 2022 (USD Million)
TABLE 25 Global prostate cancer based PCR market, by segments, 2012 to 2022 (USD million)
TABLE 26 Global prostate cancer based molecular diagnostics market, by test location, 2012 - 2022 (USD Million)
TABLE 27 Global prostate cancer based molecular diagnostics market, by region, 2012 - 2022 (USD Million)
TABLE 28 Global colorectal cancer based molecular diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 29 Global colorectal cancer based molecular diagnostics market, by technology, 2012 - 2022 (USD Million)
TABLE 30 Global colorectal cancer based PCR market, by segments, 2012 to 2022 (USD million)
TABLE 31 Global colorectal cancer based molecular diagnostics market, by test location, 2012 - 2022 (USD Million)
TABLE 32 Global colorectal cancer based molecular diagnostics market, by region, 2012 - 2022 (USD Million)
TABLE 33 Global cervical cancer based molecular diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 34 Global cervical cancer based molecular diagnostics market, by technology, 2012 - 2022 (USD Million)
TABLE 35 Global cervical cancer based PCR market, by segments, 2012 to 2022 (USD million)
TABLE 36 Global cervical cancer based molecular diagnostics market, by test location, 2012 - 2022 (USD Million)
TABLE 37 Global cervical cancer based molecular diagnostics market, by region, 2012 - 2022 (USD Million)
TABLE 38 Global liver cancer based molecular diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 39 Global liver cancer based molecular diagnostics market, by technology, 2012 - 2022 (USD Million)
TABLE 40 Global liver cancer based molecular diagnostics market, by technology, 2012 - 2022 (USD Million)
TABLE 41 Global liver cancer based molecular diagnostics market, by test location, 2012 - 2022 (USD Million)
TABLE 42 Global liver cancer based molecular diagnostics market, by region, 2012 - 2022 (USD Million)
TABLE 43 Global lung cancer based molecular diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 44 Global lung cancer based molecular diagnostics market, by technology, 2012 - 2022 (USD Million)
TABLE 45 Global lung cancer based PCR market, by segments, 2012 to 2022 (USD million)
TABLE 46 Global lung cancer based molecular diagnostics market, by test location, 2012 - 2022 (USD Million)
TABLE 47 Global lung cancer based molecular diagnostics market, by region, 2012 - 2022 (USD Million)
TABLE 48 Global blood cancer based molecular diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 49 Global blood cancer based molecular diagnostics market, by technology, 2012 - 2022 (USD Million)
TABLE 50 Global blood cancer based PCR market, by segments, 2012 to 2022 (USD million)
TABLE 51 Global blood cancer based molecular diagnostics market, by test location, 2012 - 2022 (USD Million)
TABLE 52 Global blood cancer based molecular diagnostics market, by region, 2012 - 2022 (USD Million)
TABLE 53 Global kidney cancer based molecular diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 54 Global kidney cancer based molecular diagnostics market, by technology, 2012 - 2022 (USD Million)
TABLE 55 Global kidney cancer based PCR market, by segments, 2012 to 2022 (USD million)
TABLE 56 Global kidney cancer based molecular diagnostics market, by test location, 2012 - 2022 (USD Million)
TABLE 57 Global kidney cancer based molecular diagnostics market, by region, 2012 - 2022 (USD Million)
TABLE 58 Global other cancer based molecular diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 59 Global other cancer based molecular diagnostics market, by technology, 2012 - 2022 (USD Million)
TABLE 60 Global other cancer based PCR market, by segments, 2012 to 2022 (USD million)
TABLE 61 Global other cancer based molecular diagnostics market, by test location, 2012 - 2022 (USD Million)
TABLE 62 Global other cancer based molecular diagnostics market, by region, 2012 - 2022 (USD Million)


List of Figures

FIG. 1 Oncology based Molecular diagnostics: Market segmentation
FIG. 2 Global Oncology based Molecular diagnostics market, 2012 - 2022 (USD Million)
FIG. 4 Average selling price range of diagnostic tests, 2013
FIG. 5 Key Opportunities Prioritized
FIG. 6 Oncology based Molecular diagnostics market - Porter’s analysis
FIG. 7 Company Market Share Analysis - Oncology based Molecular diagnostics Market, 2014
FIG. 8 Competitive benchmarking, by company, 2013-2014
FIG. 9 Recommendations for market participants
FIG. 10 Molecular diagnostics market PESTEL analysis
FIG. 11 Oncology based Molecular diagnostics market share, by type, 2014 & 2022
FIG. 12 Breast cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
FIG. 13 Prostate cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
FIG. 14 Colorectal cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
FIG. 15 Cervical cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
FIG. 16 Liver cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
FIG. 17 Lung cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
FIG. 18 Blood cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
FIG. 19 Kidney cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
FIG. 20 Other cancer based molecular diagnostics market, 2012 - 2022 (USD Million)
FIG. 21 Oncology based Molecular diagnostics market share, by product, 2014 & 2022
FIG. 22 Molecular diagnostic instruments market, 2012 - 2022 (USD Million)
FIG. 23 Reagents market, 2012 - 2022 (USD Million)
FIG. 24 Others market, 2012 - 2022 (USD Million)
FIG. 25 Molecular diagnostics market share, by test location, 2014 & 2022
FIG. 26 Clinics and other establishments market, 2012 - 2022 (USD Million)
FIG. 27 Point of care market, 2012 - 2022 (USD Million)
FIG. 28 Molecular diagnostics market share, by technology, 2014 & 2022
FIG. 29 PCR market, 2012 - 2022 (USD Million)
FIG. 30 Multiplex market, 2012 - 2022 (USD Million)
FIG. 31 Other market, 2012 - 2022 (USD Million)
FIG. 32 Transcription Mediated Amplification (TMA) market, 2012 - 2022 (USD Million)
FIG. 33 In situ hybridization market, 2012 - 2022 (USD Million)
FIG. 34 Sequencing market, 2012 - 2022 (USD Million)
FIG. 35 INAAT market, 2012 - 2022 (USD Million)
FIG. 36 Chips and microarrays market, 2012 - 2022 (USD Million)
FIG. 37 Mass spectrometry market, 2012 - 2022 (USD Million)
FIG. 38 Other market, 2012 - 2022 (USD Million)
FIG. 39 Oncology based Molecular diagnostics revenue share by region, 2014 & 2022
FIG. 40 North America Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 41 U.S. Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 42 Canada. Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 43 Europe Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 44 UK Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 45 Germany Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 46 France Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 47 Spain Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 48 Italy Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 49 Asia Pacific Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 50 Japan Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 51 China Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 52 India Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 53 Australia Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 54 New Zealand Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 55 Latin America Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 56 Brazil Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 57 Mexico Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 58 Colombia Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 59 MEA Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 60 South Africa Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)
FIG. 61 Saudi Arabia Oncology based Molecular diagnostics Market, 2012 - 2022 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.